A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
Clinical trial NCT01077362 · COMPLETED
Trial details
- NCT number
- NCT01077362
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2012-03-01
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.